| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | — | -93.0% |
| R&D Expense | $21.5M | — | -38.3% |
| SG&A Expense | $9.5M | — | -16.3% |
| Operating Income | -$28.9M | — | -71.9% |
| Net Income | -$27.0M | — | -91.6% |
| EPS (Basic) | -$0.95 | — | -82.7% |
| EPS (Diluted) | -$0.95 | — | -82.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $211.4M | -8.5% | -2.6% |
| Accounts Receivable | $1.3M | -75.9% | -90.8% |
| Current Assets | $216.9M | -10.2% | -22.2% |
| Total Assets | $245.4M | -9.5% | -26.0% |
| Current Liabilities | $34.4M | -5.5% | -30.4% |
| Total Liabilities | $54.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.4M | — | +44.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $34K | — | +124.8% |
| Financing Cash Flow | $16K | — | -99.9% |
| Free Cash Flow | -$19.4M | — | +44.9% |
| -44.9% |
| Stockholders' Equity | $191.4M | -10.6% | -18.1% |